Coronary vasomotor and blood flow responses to isoflavone-intact soya protein in subjects with coronary heart disease or risk factors for coronary heart disease

Clinical Science - Tập 115 Số 12 - Trang 353-359 - 2008
Carolyn Webb1,2, Christopher S. Hayward3, Mark Mason2, Charles Ilsley2, Peter Collins1,2
1Cardiac Medicine, National Heart and Lung Institute, Imperial College London, London SW3 6LY, U.K.
2Department of Cardiology, Royal Brompton and Harefield NHS Trust, London SW3 6NP, U.K.
3Department of Cardiology, St Vincent's Hospital and Victor Chang Cardiac Research Institute, Sydney, NSW 2010, Australia

Tóm tắt

Results in animals suggest favourable coronary vasomotor actions of isoflavones; however, the effects of isoflavones on the human coronary circulation have not been determined. In the present study, we therefore investigated the effects of short-term isoflavone-intact soya protein ingestion on basal coronary arterial tone and stimulated vasoreactivity and blood flow in patients with CHD (coronary heart disease) or risk factors for CHD. Seventy-one subjects were randomized, double-blind, to isoflavone-intact soya protein [active; n=33, aged 58±8 years (mean±S.D.)] or isoflavone-free placebo (n=38, aged 61±8 years) for 5 days prior to coronary angiography. In 25 of these subjects, stimulated coronary blood flow was calculated from flow velocity, measured using intracoronary Doppler and coronary luminal diameter before and after intracoronary adenosine, ACh (acetylcholine) and ISDN (isosorbide dinitrate) infusions. Basal and stimulated coronary artery luminal diameters were measured using quantitative coronary angiography. Serum concentrations of the isoflavones genistein, daidzein and equol were increased by active treatment (P<0.001, P<0.001 and P=0.03 respectively). Basal mean luminal diameter was not significantly different between groups (active compared with placebo: 2.9±0.7 compared with 2.73±0.44 mm, P=0.31). There was no difference in luminal diameter, flow velocity and volume flow responses to adenosine, ACh or ISDN between groups. Active supplement had no effect on basal coronary artery tone or stimulated coronary vasoreactivity or blood flow compared with placebo. Our results suggest that short-term consumption of isoflavone-intact soya protein is neither harmful nor beneficial to the coronary circulation of humans with CHD or risk factors for CHD. These results are consistent with recent cautions placed on the purported health benefits of plant sterols.

Từ khóa


Tài liệu tham khảo

Miksicek, 1994, Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor, J. Steroid Biochem. Mol. Biol., 49, 153, 10.1016/0960-0760(94)90005-1

Kuiper, 1998, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β, Endocrinology, 139, 4252, 10.1210/endo.139.10.6216

Adlercreutz, 2002, Phyto-oestrogens and cancer, Lancet Oncol., 3, 364, 10.1016/S1470-2045(02)00777-5

Anderson, 1995, Meta-analysis of the effects of soy protein intake on serum lipids, N. Engl. J. Med., 333, 276, 10.1056/NEJM199508033330502

Arjmandi, 2001, The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency, J. Am. Coll. Nutr., 20, 398S, 10.1080/07315724.2001.10719175

Lissin, 2000, Phytoestrogens and cardiovascular health, J. Am. Coll. Cardiol., 35, 1403, 10.1016/S0735-1097(00)00590-8

Krauss, 2000, AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association, Circulation, 102, 2284, 10.1161/01.CIR.102.18.2284

Food and Drug Administration, 1999, Food labeling, health claims, soy protein, and coronary heart disease, Fed. Reg., 57, 699

Sacks, 2006, Soy protein, isoflavones, and cardiovascular health. An American Heart Association Science Advisory for Professionals from the Nutritional Committee, Circulation, 113, 1034, 10.1161/CIRCULATIONAHA.106.171052

Figtree, 2000, Plant derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism, J. Am. Coll. Cardiol., 35, 1977, 10.1016/S0735-1097(00)00645-8

Adams, 2005, Soy protein containing isoflavones reduces the size of atherosclerotic plaques without affecting coronary artery reactivity in adult male monkeys, J. Nutr., 135, 2852, 10.1093/jn/135.12.2852

Honore, 1997, Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques, Fertil. Steril., 67, 148, 10.1016/S0015-0282(97)81872-9

Williams, 1998, Dietary soy isoflavones inhibit in vivo constrictor responses of coronary arteries to collagen-induced platelet activation, Coron. Artery Dis., 9, 759, 10.1097/00019501-199809110-00009

Squadrito, 2002, The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women, Atherosclerosis, 163, 339, 10.1016/S0021-9150(02)00013-8

Squadrito, 2003, Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study, Am. J. Med., 114, 470, 10.1016/S0002-9343(03)00059-7

Teede, 2001, Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women, J. Clin. Endocrinol. Metab., 86, 3053

Teede, 2003, Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women, Arterioscler. Thromb. Vasc. Biol., 23, 1066, 10.1161/01.ATV.0000072967.97296.4A

Yildirir, 2001, Soy protein diet significantly improves endothelial function and lipid parameters, Clin. Cardiol., 24, 711, 10.1002/clc.4960241105

Blum, 2003, Effects of soy protein on endothelium-dependent vasodilatation and lipid profile in postmenopausal women with mild hypercholesterolemia, Clin. Invest. Med., 26, 20

Teede, 2006, Randomised, controlled, cross-over trial of soy protein with isoflavones on blood pressure and arterial function in hypertensive subjects, J. Am. Coll. Nutr., 25, 533, 10.1080/07315724.2006.10719569

Pepine, 2007, Phytoestrogens and coronary microvascular function in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study, J. Womens Health, 16, 481, 10.1089/jwh.2006.0104

Webb, 1999, Effects of testosterone on coronary vasomotor regulation in men with coronary artery disease, Circulation, 100, 1690, 10.1161/01.CIR.100.16.1690

Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin. Chem., 18, 499, 10.1093/clinchem/18.6.499

Webb, 2000, 17β-Estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease, Circulation, 102, 1617, 10.1161/01.CIR.102.14.1617

van der Schouw, 2005, Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women, Circulation, 111, 465, 10.1161/01.CIR.0000153814.87631.B0

Brown, 2001, Dietary modulation of endothelial function: implications for cardiovascular disease, Am. J. Clin. Nutr., 73, 673, 10.1093/ajcn/73.4.673

Cassidy, 2003, Potential risks and benefits of phytoestrogen-rich diets, Int. J. Vitam. Nutr. Res., 73, 120, 10.1024/0300-9831.73.2.120

Setchell, 2001, Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements, J. Nutr., 131, 1362S, 10.1093/jn/131.4.1362S

Nagel, 1998, The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity, Proc. Soc. Exp. Biol. Med., 217, 300, 10.3181/00379727-217-44236

Shutt, 1972, Steroid and phyto- oestrogen binding to sheep uterine receptors in vitro, J. Endocrinol., 52, 299, 10.1677/joe.0.0520299